octreotide
PolandDrugs containing this active substance
-
The medicine is used to treat acromegaly (a disease caused by excess growth hormone), to relieve symptoms associated with neuroendocrine intestinal tumors, and to treat pituitary tumors that secrete excessive amounts of TSH hormone.
Form: powder and solvent for preparation of suspension for injection with prolonged release
Active substance Dosage octreotide 10 mg ATC: H01CB02
Manufacturer: Merckle GmbH Pharmathen International S.A. PLIVA Croatia Ltd. Teva Pharmaceuticals Europe B.V.
-
The medicine is used to treat acromegaly (a disease caused by excess growth hormone), to inhibit the growth of neuroendocrine tumors in the intestine, and to treat pituitary tumors that secrete excessive amounts of TSH hormone. It also helps to relieve symptoms associated with excessive hormone secretion by the stomach, intestines, and pancreas.
Form: powder and solvent for preparation of suspension for injection with prolonged release
Active substance Dosage octreotide 20 mg ATC: H01CB02
Manufacturer: Merckle GmbH Pharmathen International S.A. PLIVA Croatia Ltd. Teva Pharmaceuticals Europe B.V.
-
The medicine is used to treat acromegaly (a disease related to excess growth hormone), to inhibit the growth of neuroendocrine tumors in the intestine, and to treat pituitary tumors that secrete excessive amounts of TSH hormone.
Form: powder and solvent for preparation of suspension for injection with prolonged release
Active substance Dosage octreotide 30 mg ATC: H01CB02
Manufacturer: Merckle GmbH Pharmathen International S.A. PLIVA Croatia Ltd. Teva Pharmaceuticals Europe B.V.
-
The medicine is used to treat acromegaly (a disease related to excess growth hormone), to relieve symptoms associated with excessive hormone secretion by the stomach, intestines, and pancreas, to treat intestinal neuroendocrine tumors, and to treat pituitary tumors that secrete excessive amounts of TSH hormone.
Form: powder and solvent for preparation of suspension for injection
Active substance Dosage octreotide 33.6 mg ATC: H01CB02